United Guardian (UG) Depreciation & Amortization (CF) (2010 - 2026)
United Guardian's (UG) quarterly Depreciation & Amortization (CF) came in at $29366.0 in Q2 2026, up 16.74% year-over-year from $25154.0 in Q2 2025, and up 1.23% quarter-over-quarter from $29008.0 in Q1 2026.
Powered by 
Analysis
United Guardian (UG) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
United Guardian has disclosed Depreciation & Amortization (CF) across 17 years of filings, most recently posting $29366.0 for Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 16.74% year-over-year to $29366.0; the TTM figure through Jun 2026 stood at $116390.0 (up 18.48% YoY), while the FY2025 annual figure was $108200.0, up 12.84% from the prior year.
- Depreciation & Amortization (CF) came in at $29366.0 for Q2 2026 at United Guardian, up from $29008.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $34340.0 in Q3 2022 to a low of $21720.0 in Q3 2024.
- Average Depreciation & Amortization (CF) over 5 years is $27974.3, with a median of $26817.5 recorded in 2024.
- Year-over-year, Depreciation & Amortization (CF) retreated 28.61% in 2023 and rose 25.7% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $32545.0 in 2022, then slipped by 3.74% to $31327.0 in 2023, then slipped by 15.94% to $26334.0 in 2024, then increased by 16.64% to $30715.0 in 2025, then retreated by 4.39% to $29366.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $29366.0 in Q2 2026, $29008.0 in Q1 2026, and $30715.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.97 Bn | 622.21 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 441.24 Bn | 434.67 Bn | 12.70 Bn | - |
| 3 | Merck | 364.65 Bn | 357.51 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.30 Bn | 258.61 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | 1.62 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 3.97 Bn |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - | - |
| 8 | Incyte | 25.27 Bn | 20.73 Bn | 1.57 Bn | 26.48 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn | 24.20 Mn |
| 10 | United Guardian | 32.67 Mn | 23.07 Mn | 1.55 Mn | 29,366.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29,366.00 |
| Mar 31, 2026 | 29,008.00 |
| Dec 31, 2025 | 30,715.00 |
| Sep 30, 2025 | 27,301.00 |
| Jun 30, 2025 | 25,154.00 |
| Mar 31, 2025 | 25,030.00 |
| Dec 31, 2024 | 26,334.00 |
| Sep 30, 2024 | 21,720.00 |
| Jun 30, 2024 | 24,120.00 |
| Mar 31, 2024 | 23,711.00 |
| Dec 31, 2023 | 31,327.00 |
| Sep 30, 2023 | 25,444.00 |
| Jun 30, 2023 | 24,456.00 |
| Mar 31, 2023 | 24,455.00 |
| Dec 31, 2022 | 32,545.00 |
| Sep 30, 2022 | 34,340.00 |
| Jun 30, 2022 | 34,255.00 |
| Mar 31, 2022 | 34,256.00 |
| Dec 31, 2021 | 39,049.00 |
| Sep 30, 2021 | 36,903.00 |